OTS-167 | Interleukin Related interleukin-related.com

Product Name :
OTS-167

Search keywords :
PEG3

drugId :
null

Target Vo:
Maternal embryonic leucine zipper kinase

Target Vo Short Name :
MELK

Moa_Name:
Maternal embryonic leucine zipper kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Oncotherapy Science, Inc

Active Company_Name :
Oncotherapy Science, Inc

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Myelodysplastic Syndromes

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
V5-tag Antibody
NQO1 Antibody (YA697)
Ki67 Antibody (YA717): Ki67 Antibody (YA717) is a non-conjugated and Mouse origined monoclonal antibody about 359 kDa, targeting to Ki67. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts